Valneva News and Activities

Valneva is owned by Groupe Grimaud. Groupe Grimaud has a direct presence in 3 countries.

Groupe Grimaud has 3 subsidiaries including Valneva, Valneva Austria and Valneva Canada.

They are in:

• Biotechnology50%
• Healthcare50%

View the org chart displaying its 26 main executives

Most searched biographies at Valneva

• Thomas Lingelbach, President and Chief Executive Officer
• James Connolly, Director
• Anne-Marie Graffin, Chairman of the Board

Create your alert
to follow the executive moves at Valneva.

Groupe Grimaud has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Valneva

• In The News – Valneva

Social media about Valneva

• Valneva on Wikipedia, Google News & Yahoo Finance
• Valneva on LinkedIn, X (Twitter) & YouTube